Radiopharm Theranostics Ltd ADR (RADX)

$16.19 +10.59 (189.11%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 10,245
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Radiopharm Theranostics Limited engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs. It develops RAD 204, a programmed death-ligand 1 (PD-L1) for the treatment of non-small cell lung cancer (NSCLC); RAD 202, a human epidermal growth factor receptor 2 (HER2) to treat breast cancer and other solid tumors; and RAD 301, a diagnostic radiopharmaceutical targeting avß6 integrin in pancreatic ductal adenocarcin...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 3 9824 5254
Fax: 61 3 9822 7735
Address:
62 Lygon Street, Level 3, Carlton, Australia
Lalalilala
Lalalilala Sep. 13 at 12:55 PM
$RADX @Radiolsotop25, Your optimism, which predicts 5 times the current price, still seems overvalued to me compared to phase 2B results.... Perhaps if all the planets align in Q4 we will be at this price on December 20th...(6.5 x 5$250,000,000 before entering 1 phase III and 3 possible passages into phase 2....don't you think that's very high?
0 · Reply
RadioIsotope25
RadioIsotope25 Sep. 12 at 11:06 PM
$RADX https://m.youtube.com/watch?v=IRiRqoQRbj4
0 · Reply
RadioIsotope25
RadioIsotope25 Sep. 12 at 8:28 PM
$RADX https://www.onclive.com/view/lutetium-lu-177-dotatate-yields-partial-responses-in-metastatic-bronchopulmonary-neuroendocrine-tumors#:~:text=Key%20Takeaways,1
0 · Reply
RadioIsotope25
RadioIsotope25 Sep. 12 at 8:05 PM
$RADX Hopefully it opens at $13.00 next week
0 · Reply
Lalalilala
Lalalilala Sep. 12 at 7:33 PM
$RADX A close above $6.93, which is today's resistance number 3, would bode well for next week! 🧐
0 · Reply
Apapaz
Apapaz Sep. 12 at 6:51 PM
$RADX 2324 shares at cost basis of 4.7…LFG
1 · Reply
Lalalilala
Lalalilala Sep. 12 at 6:29 PM
$RADX I just added 650 more at $6.91 and that brought my average up but too bad, I'll take responsibility. Total : 3800 price $6.26. 🤞🤞🤞🤞
1 · Reply
RadioIsotope25
RadioIsotope25 Sep. 12 at 6:07 PM
$RADX Shorts stuck
1 · Reply
History101
History101 Sep. 12 at 5:10 PM
$RADX my biotechs are all in the red today, except for RADX, $BIXT & $CAMP....GLTALS!!
0 · Reply
IanMaui
IanMaui Sep. 12 at 5:01 PM
$RADX I just registered for CEO event, 8pm 23rd. SO, guessing we get readouts between now and then.
0 · Reply
Latest News on RADX
No data available.
Lalalilala
Lalalilala Sep. 13 at 12:55 PM
$RADX @Radiolsotop25, Your optimism, which predicts 5 times the current price, still seems overvalued to me compared to phase 2B results.... Perhaps if all the planets align in Q4 we will be at this price on December 20th...(6.5 x 5$250,000,000 before entering 1 phase III and 3 possible passages into phase 2....don't you think that's very high?
0 · Reply
RadioIsotope25
RadioIsotope25 Sep. 12 at 11:06 PM
$RADX https://m.youtube.com/watch?v=IRiRqoQRbj4
0 · Reply
RadioIsotope25
RadioIsotope25 Sep. 12 at 8:28 PM
$RADX https://www.onclive.com/view/lutetium-lu-177-dotatate-yields-partial-responses-in-metastatic-bronchopulmonary-neuroendocrine-tumors#:~:text=Key%20Takeaways,1
0 · Reply
RadioIsotope25
RadioIsotope25 Sep. 12 at 8:05 PM
$RADX Hopefully it opens at $13.00 next week
0 · Reply
Lalalilala
Lalalilala Sep. 12 at 7:33 PM
$RADX A close above $6.93, which is today's resistance number 3, would bode well for next week! 🧐
0 · Reply
Apapaz
Apapaz Sep. 12 at 6:51 PM
$RADX 2324 shares at cost basis of 4.7…LFG
1 · Reply
Lalalilala
Lalalilala Sep. 12 at 6:29 PM
$RADX I just added 650 more at $6.91 and that brought my average up but too bad, I'll take responsibility. Total : 3800 price $6.26. 🤞🤞🤞🤞
1 · Reply
RadioIsotope25
RadioIsotope25 Sep. 12 at 6:07 PM
$RADX Shorts stuck
1 · Reply
History101
History101 Sep. 12 at 5:10 PM
$RADX my biotechs are all in the red today, except for RADX, $BIXT & $CAMP....GLTALS!!
0 · Reply
IanMaui
IanMaui Sep. 12 at 5:01 PM
$RADX I just registered for CEO event, 8pm 23rd. SO, guessing we get readouts between now and then.
0 · Reply
RadioIsotope25
RadioIsotope25 Sep. 12 at 3:05 PM
Shorts think they know more than Lantheus and they are a $3-4 billion dollar company invested at $11.70 per share in first quarter. Not sure why they would ever feel that way. Only thing I see is short orders to act as speed bumps. I predict dosimetry will predict efficacy for pdl-1 and that means high odds of efficacy in the pdl-1. And the fundamental buyers aka Lantheus knows this imo. Secondly the brain mets imaging data if it repeats what we saw in phase 2a then we should be golden. I am speculating good data in both of these key areas. 🔑 Only invest what you can afford to. $RADX
1 · Reply
RadioIsotope25
RadioIsotope25 Sep. 12 at 2:21 PM
$RADX 7 more full trading days before the 24th and he talks about company.
0 · Reply
RadioIsotope25
RadioIsotope25 Sep. 12 at 1:46 PM
$RADX Possible this is $20 after news.
1 · Reply
RadioIsotope25
RadioIsotope25 Sep. 12 at 12:39 PM
$RADX $CHRS $CATX
0 · Reply
RadioIsotope25
RadioIsotope25 Sep. 12 at 12:33 PM
$RADX Lantheus is an aggregator in this space. $RADX $CSBR $LNTH
0 · Reply
IanMaui
IanMaui Sep. 12 at 12:31 PM
$RADX New webinar with $RADX CEO Riccardo Canevari is happening on Wednesday 24th September at 10am AEST (Tuesday 23rd September 8pm EST). "Hear directly from Managing Director and CEO Riccardo Canevari as he shares clinical strategy insights, pipeline progress and how Radiopharm is reshaping the oncology landscape. Don’t miss this opportunity to engage with a radiopharma innovator at the forefront of precision oncology." Register here: https://kalkinemedia.com/webinar/register/82078972927
1 · Reply
Manpreet00
Manpreet00 Sep. 12 at 5:16 AM
$RADX one thing about them Australians is they tend overvalue their biotech companies so we might be sitting on a gold mine here if the trial data is positive this month
0 · Reply
RadioIsotope25
RadioIsotope25 Sep. 11 at 11:36 PM
$RADX Deep value here Lantheus infused capital in at $11.70 in first quarter
0 · Reply
IanMaui
IanMaui Sep. 11 at 11:30 PM
$RADX I am getting feeling we get 2 press releases before the CEO's conf call. and he will use call to review results and next steps.
2 · Reply
e17
e17 Sep. 11 at 11:02 PM
$RADX Have to get in where you fit in here, it’s already difficult to get a price that you like now. It will only be harder to do in the future as we move up. GLA
0 · Reply
outlawinvestor1
outlawinvestor1 Sep. 11 at 10:18 PM
$RADX and it was 100 (not just 1) shares too!
0 · Reply
outlawinvestor1
outlawinvestor1 Sep. 11 at 10:16 PM
$RADX $7 achieved!!!!! onward to $70!
0 · Reply